STERIS Current Ratio 2010-2022 | STE

Current and historical current ratio for STERIS (STE) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. STERIS current ratio for the three months ending June 30, 2022 was 2.04.
STERIS Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-06-30 $1.85B $0.91B 2.03
2022-03-31 $1.88B $0.92B 2.04
2021-12-31 $1.93B $0.90B 2.13
2021-09-30 $1.91B $0.79B 2.42
2021-06-30 $2.01B $1.15B 1.75
2021-03-31 $1.21B $0.58B 2.10
2020-12-31 $1.18B $0.51B 2.33
2020-09-30 $1.15B $0.44B 2.64
2020-06-30 $1.10B $0.48B 2.29
2020-03-31 $1.22B $0.50B 2.43
2019-12-31 $1.05B $0.45B 2.34
2019-09-30 $1.03B $0.43B 2.41
2019-06-30 $1.04B $0.43B 2.41
2019-03-31 $1.05B $0.47B 2.27
2018-12-31 $1.02B $0.40B 2.56
2018-09-30 $0.98B $0.37B 2.63
2018-06-30 $0.99B $0.37B 2.65
2018-03-31 $0.99B $0.40B 2.48
2017-12-31 $1.03B $0.37B 2.82
2017-09-30 $1.03B $0.37B 2.80
2017-06-30 $1.03B $0.35B 2.91
2017-03-31 $1.02B $0.38B 2.67
2016-12-31 $0.97B $0.35B 2.77
2016-09-30 $0.96B $0.37B 2.58
2016-06-30 $0.95B $0.36B 2.63
2016-03-31 $0.97B $0.40B 2.43
2015-12-31 $0.97B $0.36B 2.68
2015-09-30 $0.71B $0.26B 2.77
2015-06-30 $0.74B $0.26B 2.79
2015-03-31 $0.72B $0.28B 2.54
2014-12-31 $0.67B $0.24B 2.75
2014-09-30 $0.67B $0.25B 2.75
2014-06-30 $0.68B $0.23B 2.93
2014-03-31 $0.68B $0.26B 2.65
2013-12-31 $0.62B $0.20B 3.08
2013-09-30 $0.63B $0.20B 3.19
2013-06-30 $0.63B $0.20B 3.19
2013-03-31 $0.61B $0.22B 2.81
2012-12-31 $0.62B $0.23B 2.73
2012-09-30 $0.61B $0.23B 2.61
2012-06-30 $0.66B $0.27B 2.43
2012-03-31 $0.65B $0.28B 2.34
2011-12-31 $0.63B $0.30B 2.14
2011-09-30 $0.63B $0.30B 2.07
2011-06-30 $0.66B $0.31B 2.18
2011-03-31 $0.71B $0.35B 2.05
2010-12-31 $0.64B $0.31B 2.05
2010-09-30 $0.63B $0.28B 2.22
2010-06-30 $0.61B $0.29B 2.12
2010-03-31 $0.58B $0.20B 2.92
2009-12-31 $0.63B $0.18B 3.57
2009-09-30 $0.59B $0.18B 3.33
2009-06-30 $0.54B $0.17B 3.30
2009-03-31 $0.55B $0.20B 2.74
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $16.630B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
Alcon (ALC) Switzerland $28.513B 24.14
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Globus Medical (GMED) United States $5.928B 30.24
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23